Drug
Clemastine clinical trials
- studies test it
- 13
- open now
- 6
- in phase 3
- 2
- first study started
- 2011
Keep track of what changes. Save the Clemastine studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Combined with it in one product
Studies by the year they started
13 studies that test it; most in 2022 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 8
- Phase 3
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 12
University of California, San Francisco (5) · Qilu Hospital of Shandong University (1) · Cambridge University Hospitals NHS Foundation Trust (1) · Chinese Academy of Medical Sciences, Fuwai Hospital (1) · LMU Klinikum (1) · Bridget LaMonica Ostrem, M.D., Ph.D. (1) · University of Illinois at Chicago (1) · Amsterdam UMC, location VUmc (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Clemastine is read from its arms, and is right about nine times in ten.
Testing it · 13
- Neonatal White Matter Injury Trial (WRAP)RecruitingPhase 1Bridget LaMonica Ostrem, M.D., Ph.D.NCT07688746Written as Clemastine fumarate
- Assessing Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyRecruitingPhase 1/2University of California, San FranciscoNCT05359653Written as Clemastine Fumarate
- Clemastine for Improving White Matter and Boosting Antidepressant Response in Late-life DepressionRecruitingPhase 2University of Illinois at ChicagoNCT06591091Written as Clemastine Fumarate
- Assessing Changes in Multi-parametric MRI in Patients With Acute Demyelinating Lesions Taking Clemastine Fumarate as a Myelin Repair TherapyNot yet recruitingPhase 1/2University of California, San FranciscoNCT06065670Written as Clemastine Fumarate
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)RecruitingPhase 2University of California, San FranciscoNCT02521311Written as Clemastine
- Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin PlasticityNot yet recruitingPhase 2LMU KlinikumNCT06315972Written as clemastine (8 mg/day)
- Clemastine Fumarate as Remyelinating Treatment in Internuclear Ophthalmoparesis and Multiple SclerosisTerminatedPhase 3Amsterdam UMC, location VUmcNCT05338450Written as Clemastine Fumarate
- Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams SyndromeCompletedPhase 2Qilu Hospital of Shandong UniversityNCT06315699Written as Clemastine Fumarate Tablets
- CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying TherapyCompletedPhase 2Cambridge University Hospitals NHS Foundation TrustNCT05131828Written as Metformin and clemastine in combination
- Assessment of Clemastine Fumarate as a Remyelinating Agent in Multiple SclerosisCompletedPhase 2University of California, San FranciscoNCT02040298Written as Clemastine
- Clemastine in Cardiovascular SurgeryCompletedNot applicableChinese Academy of Medical Sciences, Fuwai HospitalNCT03826004Written as Clemastine
- Effect of Clemastine Fumarate on Color Vision in Healthy ControlsCompletedPhase 1University of California, San FranciscoNCT02613091Written as Clemastine fumarate
- Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic DermatitisStatus unknownPhase 3Azidus BrasilNCT01239719Written as Dexamethasone + clemastine
Given in every arm · 1 — Clemastine is usual care beside what is tested
As the comparator · 1 — what is tested is compared with Clemastine
Codes
What other systems call Clemastine · ClinicalTrials.gg INT007226
- MeSH (NLM) D002974ClemastineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 95QN29S1IDCLEMASTINEConfirmed FDA, NLM, Wikidata
- RxNorm 2578Confirmed FDA, Wikidata
- Wikidata Q418145clemastineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61682ClemastineOne source FDA
- DrugBank DB00283One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D002974 | Clemastine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 95QN29S1ID | CLEMASTINE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2578 | — | Confirmed FDA, Wikidata |
| Wikidata | Q418145 | clemastine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61682 | Clemastine | One source FDA |
| DrugBank | DB00283 | — | One source Wikidata |
Also registered as clemastine fumarate (UNII 19259EGQ3D · RxNorm 142430).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.